advertisement

obesity

understanding the childhood obesity epidemic: environment, genetics and education

the entire society has to work together to end childhood obesity, and the onus cannot be put on parents or just one group of people.
angelica bottaro
sep 18 2024

the toll of obesity: long-term impact, access to care and insurance support

“people living with obesity have a right to tackle their disease, to be treated just like someone who has migraines or hypertension. it’s just basic human rights."
angelica bottaro
sep 6 2024

signs point to glp-1 drug innovation beyond wegovy and ozempic

with the explosive demand for breakthrough drugs like wegovy and ozempic for weight loss, pharmaceutical companies are racing to improve these medications and target additional conditions.
karen hawthorne
sep 6 2024

leaders in health: dr. sean wharton and compassion in obesity medicine

while the mantra “eat less and move more” continues to be advised by some healthcare practitioners for people living with obesity, dr. sean wharton has brought greater compassion and understanding to the healthcare community and his own clinic.
karen hawthorne
aug 21 2024

leaders in health: dr. sasha high and teaching people why weight loss isn’t about food

dr. sasha high has embraced holistic-style treatments after more than a decade of learning and seeing the science of obesity medicine evolve.
karen hawthorne
jul 3 2024

study reveals diabetes drug as potential treatment for obstructive sleep apnea

tirzepatide may be used for diabetes, but it's well on its way to becoming the first-ever drug therapy for obstructive sleep apnea (osa).
angelica bottaro
jun 25 2024

next-level health: obesity – the hidden pandemic and new answers

while new drugs like ozempic and wegovy are effective, obesity requires a comprehensive approach to treatment, tailored to meet each patient’s needs.
andrew haller, phd, founder of healthstorecanada
jun 24 2024

study highlights wegovy's expanding benefits from obesity to heart disease

the obesity drug wegovy shows promise in treating heart disease as well as obesity, diabetes, and renal disease.
angelica bottaro
may 29 2024
powered by
obesity canada
powered by
obesity matters
powered by
diabetes canada

understanding the childhood obesity epidemic: environment, genetics and education

the entire society has to work together to end childhood obesity, and the onus cannot be put on parents or just one group of people.
angelica bottaro
sep 18 2024

the toll of obesity: long-term impact, access to care and insurance support

“people living with obesity have a right to tackle their disease, to be treated just like someone who has migraines or hypertension. it’s just basic human rights."
angelica bottaro
sep 6 2024

signs point to glp-1 drug innovation beyond wegovy and ozempic

with the explosive demand for breakthrough drugs like wegovy and ozempic for weight loss, pharmaceutical companies are racing to improve these medications and target additional conditions.
karen hawthorne
sep 6 2024

leaders in health: dr. sean wharton and compassion in obesity medicine

while the mantra “eat less and move more” continues to be advised by some healthcare practitioners for people living with obesity, dr. sean wharton has brought greater compassion and understanding to the healthcare community and his own clinic.
karen hawthorne
aug 21 2024
powered by
obesity canada

leaders in health: dr. sasha high and teaching people why weight loss isn’t about food

dr. sasha high has embraced holistic-style treatments after more than a decade of learning and seeing the science of obesity medicine evolve.
karen hawthorne
jul 3 2024

study reveals diabetes drug as potential treatment for obstructive sleep apnea

tirzepatide may be used for diabetes, but it's well on its way to becoming the first-ever drug therapy for obstructive sleep apnea (osa).
angelica bottaro
jun 25 2024

next-level health: obesity – the hidden pandemic and new answers

while new drugs like ozempic and wegovy are effective, obesity requires a comprehensive approach to treatment, tailored to meet each patient’s needs.
andrew haller, phd, founder of healthstorecanada
jun 24 2024

study highlights wegovy's expanding benefits from obesity to heart disease

the obesity drug wegovy shows promise in treating heart disease as well as obesity, diabetes, and renal disease.
angelica bottaro
may 29 2024
powered by
obesity matters

advertisement

advertisement